Robert (Bob) W. Duggan
Robert W. Duggan has been a director and chairman of the Board of Directors since November 2017. From 2015 Mr. Duggan has been CEO of Duggan Investments, a venture capital and public equity investment firm. His venture investments primarily focus on patient-friendly breakthrough solutions to complex diseases of aging. From 2008 to 2015, Mr. Duggan was Chairman, CEO and the largest investor in Pharmacyclics, a patient-friendly, science-based, employee-driven developer of small-molecule medicines for the treatment of cancers. Pharmacyclics was sold to AbbVie for $21 billion in May of 2015. From 1990 to 2003, Mr. Duggan was Chairman of the Board of Computer Motion. From 1997 to 2003, Mr. Duggan also served as Chief Executive officer of Computer Motion. In June of 2003, Computer Motion merged with Intuitive Surgical [NASDAQ:ISRG]. This culminated in Computer Motion shareholders owning a 1/3 interest in the resulting business. From 2003 to 2011, Mr. Duggan served on the Board of Directors of Intuitive Surgical. Mr. Duggan received a U.S. Congressman's Medal of Merit from Ron Paul in 1985 and in 2000 he was named a Knight of the Legion D’Honor by President Jacques Chirac of France. He is a member of the University of California at Santa Barbara Foundation Board of Trustees. Mr. Duggan has also funded two Chairs in Mathematical, Life, and Physical Sciences as well as a Chair in Religious studies at the University of California at Santa Barbara.